A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis

Clinical trial NCT04469062 · WITHDRAWN

Trial details

NCT number: NCT04469062
Sponsor: Eli Lilly and Company
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2021-04-20
Primary completion: 2024-03-13
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.